Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,929 | -29,039 | -17,031 | -6,670 | -37,874 |
| Depreciation Amortization | 1,916 | 1,004 | 628 | 279 | 1,164 |
| Accounts payable and accrued liabilities | -74 | 101 | 18 | 24 | -183 |
| Other Working Capital | -733 | 519 | -1 | -669 | 516 |
| Other Operating Activity | 6,162 | 10,000 | 4,935 | 880 | 2,709 |
| Operating Cash Flow | $-24,657 | $-17,416 | $-11,451 | $-6,155 | $-33,669 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,226 | 5,226 | 4,946 | 4,343 | 3,075 |
| PPE Investments | -187 | -167 | -89 | -71 | -244 |
| Investing Cash Flow | $5,039 | $5,059 | $4,857 | $4,272 | $2,831 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,000 | 5,000 | 5,000 | N/A | 15,000 |
| Common Stock Issued | 20,863 | 15,916 | 15,913 | 15,902 | 65 |
| Other Financing Activity | -12,682 | -2,562 | -807 | -754 | -11,905 |
| Financing Cash Flow | $13,181 | $18,354 | $20,106 | $15,149 | $3,161 |
| Beginning Cash Position | 21,055 | 21,055 | 21,055 | 21,055 | 48,732 |
| End Cash Position | 14,618 | 27,052 | 34,567 | 34,320 | 21,055 |
| Net Cash Flow | $-6,438 | $5,997 | $13,512 | $13,265 | $-27,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,657 | -17,416 | -11,451 | -6,155 | -33,669 |
| Capital Expenditure | -187 | -167 | -89 | -71 | -244 |
| Free Cash Flow | -24,844 | -17,583 | -11,540 | -6,227 | -33,913 |